Search

Displaying results 31 - 40 of 52 in total
  1. Drug

    Izalontamab brengitecan

    go.drugbank.com/drugs/DB22567
    Investigational

    Izalontamab brengitecan is under investigation in clinical trial NCT07054567 (A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial

  2. Drug

    Fruquintinib

    go.drugbank.com/drugs/DB11679
    ApprovedInvestigational

    The first approach can be exemplified by [bevacizumab], a VEGF-A trap antibody. … Although [bevacizumab] is successful in sustaining target inhibition, mandatory intravenous dosing, immunogenicity, and the potential to induce autoimmune diseases hinder its clinical application.

  3. Indication

    Unresectable Hepatocellular Carcinoma (HCC)

    go.drugbank.com/conditions/DBCOND0083730
    Drugs: Atezolizumab · Bevacizumab · Durvalumab · Ipilimumab · Lenvatinib · Nivolumab +2 more
  4. Drug

    Apomab

    go.drugbank.com/drugs/DB15022
    Investigational

    Apomab is under investigation in clinical trial NCT00851136 (A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced

  5. Indication

    Metastatic Non-squamous Non Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0044105
    Drugs: Atezolizumab · Bevacizumab · Carboplatin · Paclitaxel · Pemetrexed · Sevabertinib
  6. Indication

    Metastatic Renal Cell Carcinoma ( mRCC)

    go.drugbank.com/conditions/DBCOND0123126
    Drugs: Aldesleukin · Bevacizumab · Medroxyprogesterone acetate · Nivolumab · Pembrolizumab
  7. Indication

    Neovascular (Wet) Age-related Macular Degeneration (nAMD)

    go.drugbank.com/conditions/DBCOND0158368
    Drugs: Aflibercept · Bevacizumab · Brolucizumab · Faricimab · Pegaptanib · Ranibizumab
  8. Drug

    Tipiracil

    go.drugbank.com/drugs/DB09343
    ApprovedInvestigational

    Tipiracil is a thymidine phosphorylase inhibitor. It is used in combination with trifluridine, in a ratio of 1:0.5, to form TAS-102. The main function of Tipiracil in TAS-102 is to increase trifluridine bioavailability by inhibiting its ...

  9. Drug

    Parsatuzumab

    go.drugbank.com/drugs/DB14897
    Investigational

    Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced

  10. Drug

    SS1(dsFv)-PE38

    go.drugbank.com/drugs/DB17579
    Investigational

    SS1(dsFv)-PE38 is under investigation in clinical trial NCT01051934 (A Phase I Trial of SS1 (Dsfv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-small Cell Lung Adenocarcinoma